Home
Mark Andrew Wilson, Chief Legal Officer: Nektar Therapeutics NKTR Sell · Filed 24/02/22
Trade details
- Type
- Insider sale
- Amount
- $5,172.08
- Shares · price
- 7,606 sh · $0.68 a share
- Held after
- 236,674 sh
- Trade date
- 24/02/20
- Filed
- 24/02/22
- Days to filing
- 2 days
Sold 3.1% of holdings
- Share of holding sold
- 3.1%
Nektar Therapeutics trades, last 26 weeks
What else happened in Nektar Therapeutics around then
Filed or reported within 30 days of the trade day · 24/01/21~24/03/21Mark Andrew Wilson's recent trades
- Mark Andrew Wilson
Planned saleNektar Therapeutics
Planned saleNektar Therapeutics
NKTR
$5.7M
78,510 sh
$5.7M
Filed 03/13
Traded 03/13
- Mark Andrew Wilson
SellNektar Therapeutics
SellNektar Therapeutics
NKTR
$34.2K
630 sh
$34.2K
Filed 25/11/25
Traded 25/11/25
- Mark Andrew Wilson
Planned saleNektar Therapeutics
Planned saleNektar Therapeutics
NKTR
$37.1K
630 sh
$37.1K
Filed 25/11/25
Traded 25/11/25
- Mark Andrew Wilson
SellNektar Therapeutics
SellNektar Therapeutics
NKTR
$18K
676 sh
$18K
Filed 25/08/21
Traded 25/08/19
- Mark Andrew Wilson
Planned saleNektar Therapeutics
Planned saleNektar Therapeutics
NKTR
$18K
676 sh
$18K
Filed 25/08/19
Traded 25/08/19